echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Clin Infect Dis: The greatest risk factor for death from COVID-19 infection

    Clin Infect Dis: The greatest risk factor for death from COVID-19 infection

    • Last Update: 2020-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    DECEMBER 20, 2020 /--- In a study published in the journal Clinical Infection Diseases, researchers evaluated nearly 67,000 hospitalized COVID-19 patients in 613 hospitals nationwide to determine the link between certain common patient characteristics and the risk of dying from COVID-19.
    study, conducted by researchers at the University of Maryland School of Medicine (UMSOM), showed that hospitalized COVID-19 patients were at higher risk of death if they were male, obese or had complications of diabetes or high blood pressure.
    their analysis found that men had a 30 percent higher risk of death than women of the same age and health status.
    risk of death from obesity, high blood pressure or poorly managed diabetes compared to those without these conditions.
    20 to 39-year-olds with these diseases are at greatest risk than their healthy peers.
    (Photo: Www.pixabay.com) study author Anthony D. Harris said, "With cases and hospitalizations in the United States continuing to soar to record highs in December, the risk of death for coVID-19 patients in hospital is imminent."
    understand which hospitalized COVID-19 patients are most likely to die, can help guide difficult treatment decisions.
    " for example, high-risk patients can receive remdesivir treatment earlier during their stay in hospital to help prevent serious complications, or may consider closer monitoring or staying in the ICU.
    In determining which COVID-19 patients can benefit most from the new monoclonal antibody therapy, healthcare providers may also need to consider these risks, which can reduce the risk of hospitalization if new monoclonal antibody therapy is given in the first few days of infection.
    remains the strongest predicted indicator of COVID-19 mortality.
    , nearly 19 percent of hospitalized COVID-19 patients died from infection, while pediatric patients had the lowest mortality rate, at less than 2 percent.
    the highest mortality rate among people aged 80 and over is as high as 34 per cent, with mortality increasing with age.
    E. Goodman, lead author of the study, said: "Older patients still have the highest risk of death, but younger patients with obesity or high blood pressure have the highest risk of death relative to other patients of the same age.
    may want to give more attention to these young patients during their stay in hospital to ensure that they can detect any complications quickly.
    researchers also found some good news in the study.
    death rate among hospitalized patients has dropped significantly since the early days of the pandemic in April.
    this may be due to the availability of new therapies and the medical community's increased understanding of how to properly manage and care for inpatients.
    (Bioon.com) Source: New study of the greatest risk factors of mortality COVID-19 Original source: Clinical Health Diseases (2020). DOI: 10.1093/cid/ciaa1787。
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.